10.1016/j.npep.2018.07.003 Neuropeptides 39 ZhangL.ZhangL.LiL.HlscherC
showed that tirzepatide 10 mg exhibited a greater reduction in the insulin resistance index HOMA2-IR compared to dulaglutide and placebo at 26 weeks [74]
Access to medically supervised GLP-1 treatment without needing to find and book an obesity medicine specialist locally is a meaningful difference for a lot of patients
Knowing both the benefits and risks helps set realistic expectations and allows for a more informed decision
Samples are evaluated for the presence of specific compounds, not for the general presence of foreign substances
Second, study populations have been heterogeneous with respect to diabetes status, obesity, renal function, baseline cardiovascular disease, and HF phenotype, which may limit generalizability